EmVenio Insights

This April, the EmVenio and PCM Trials team traveled to Washington, D.C., for the 2025 World Vaccine Congress. In addition to attending informative panels, lectures and sessions on everything from research to commercial manufacturing of vaccines, our team hosted a…

DENVER, Colo., May 12, 2025 – Clinical trials organization EmVenio Research was named winner for Best Clinical Trial Company at the 2025 Vaccine Industry Excellence Awards. The award ceremony was held April 22 during the 2025 World Vaccine Congress in…

EmVenio and PCM Trials attended the 16th annual SCOPE Summit, sharing insights on improving clinical trial inclusivity and accessibility. Highlights included discussions on recruiting underrepresented populations, addressing rural and tribal community challenges, and showcasing their mobile research site to demonstrate community-focused trial solutions.

EmVenio and PCM Trials attended the 16th annual SCOPE Summit, sharing insights on improving clinical trial inclusivity and accessibility. Highlights included discussions on recruiting underrepresented populations, addressing rural and tribal community challenges, and showcasing their mobile research site to demonstrate community-focused trial solutions.

The clinical research industry continues to evolve, with efficiency and precision taking center stage in study start-up processes. A recent webinar, Efficient Study Start-Up: Best Practices from a Clinical Site Network, presented by Xtalks, explored the intricacies of streamlining study…

The Society for Clinical Research Sites recently hosted a webinar featuring EmVenio and RealTime eClinical Solutions about “Standardizing Scalable and Compliant Technology for Hybrid Trials,” which discussed the role technology plays in hybrid clinical trials. Phillip Stanford, EmVenio’s senior director…

At EmVenio, we believe community intervention is the first step to creating inclusivity and trust in clinical research. This month, we had the privilege of meeting community members of the Greater Atlanta area at “Reflections Atlanta: Illuminating Diversity in Medicine…

EmVenio has been an active member in the Society of Clinical Research Sites since our founding in 2022, and many of our team members have been involved in the SCRS community over the course of their careers. We also recently…

EmVenio leadership and staff gathered in late September for a ribbon-cutting and open house at one of our first clinical trial research centers within the Prime Healthcare hospital system. This location is inside the Southern Regional Medical Center in Riverdale,…

Discover an informative webinar that revolutionizes the impact of hybrid clinical trials by implementing patient-centric solutions that fast-track the development of life-changing therapies. Historically, trials necessitated in-person participation, requiring volunteers to travel to research sites. On average, travel times amounted to two hours, excluding the time spent…

The United States Food and Drug Administration has issued several guidances throughout the last five years to enhance the diversity, equity, and inclusivity of clinical trials. These are significant and much-needed additions to the industry, supporting EmVenio’s mission of providing…

Pre-study visits now available for clinical research organizations and trial sponsors DURHAM, N.C., Aug. 1, 2024 /PRNewswire/ — EmVenio Research announced today it has opened two dedicated research centers within the Prime Healthcare hospital system, located in the greater Dallas and Atlanta areas. The sites are currently open…